Surgical Glue Market Size – Industry Structure Evaluation, Demand Drivers Analysis, Regional Growth Analysis and Identification, Competitive Positioning Review & Global Market Size Forecast to 2034
Overview
Surgical Glue Market was valued at US $ 8.24 Bn. in 2025, and it is expected to reach US $ 19.12 Bn. by 2034 with a CAGR of 9.8% during the forecast period.
Surgical Glue Market Overview:
Surgical glue, also known as 2-octyl cyanoacrylate (DERMABOND), is a wound-healing polymer. It is effective for linear lacerations under low stress since it acts quickly, polymerizing in 30 seconds at room temperature. Surgical glue is a biological or synthetic substance used to prevent air or liquid from leaking in wounds after operations and traumatic injuries. Health professionals and consumers refer to it as a surgical adhesive and sealant.
Surgical Glue Market Size, Growth and Share Analysis
To know about the Research Methodology:-Request Free Sample Report
Surgical Glue Market Trends:
Plastic surgeries are becoming more popular as disposable income rises, consumer awareness rises, and surgical techniques become more technologically advanced. Breast augmentation, liposuction, nose reshaping, eyelid surgery, and facelift were among the most popular cosmetic operations in 2025. Tumor removal, laceration repair, maxillofacial surgery, scar revision, and hand surgery were the top five reconstruction treatments in 2025. Surgical glue market growth is being supported by the procedures described above.
Surgical Glue Market Dynamics:
People in both developing and developed economies are spending a lot of money on healthcare services as their health concerns grow and their disposable income rises. According to the Centers for Disease Control and Prevention (CDC), total national health spending in the United States was US $5.2 trillion in 2022, with US $10,990 spent per capita. According to the Office for National Statistics (ONS), the United Kingdom's overall healthcare spending in 2022 was US $582.8 billion.
As a result of growing medical awareness, rising disposable income, and numerous improvements in surgical facilities, countries are increasing their spending on healthcare and related facilities. Thus, patients suffering from various ailments are going for surgeries (better and quick treatment alternatives), which, in turn, is driving the surgical glue market growth.
Surgical glue has a number of drawbacks that affect its usability and safety, including allergic responses, wound dehiscence, and skin infections. Also, it is classified as class II by the FDA and class B by the Drugs and Cosmetics Acts (1940) in India, making it rather dangerous and necessitating clinical trials as well as legal complications. The safety, quality, and performance of these materials are all important aspects that must be evaluated rigorously for public health reasons, resulting in complicated and harsh requirements for their affiliation. As a result, these challenges are impeding the surgical glue market's growth.
Stakeholders in the surgical glue market are likely to devote more resources to developing novel surgical glue with superior physical and functional features. For example, in June 2022, a research team from Technion – Israel Institute of Technology revealed the development of a new non-toxic, biodegradable, and flexible surgical adhesive. The new product can be used for both internal and external surgeries. Surgical glue is mainly utilized for external applications only, despite developing as a reliable alternative to surgical staplers and sutures.
Surgical Glue Market Segment Analysis:
Based on End-user, the Surgical Glue market is segmented as, hospitals, clinics, and others. In 2025, the hospital segment held xx% of the overall market share in terms of revenue. This is mostly due to an increase in the number of procedures performed around the world as a result of the growing elderly population and the prevalence of various ailments.
Also, doctors are increasingly using them to limit blood loss and accomplish effective hemostasis and wound closure in trauma cases, injuries, and surgical procedures. The inexpensive cost of these products, together with their ease of use and reduced risk of problems, provide major benefits, driving the market growth.
Detailed information about all segments is covered in the MMR’s report.
Surgical Glue Market Regional Insights:
During the forecast period, North America is expected to be the fastest-growing surgical glue industry. Increasing investments in medical adhesives R&D and their various applications in various procedures conducted in the region are among the factors that have led to the growth. According to the Heart Disease & Stroke Statistical Fact Sheet 2025, congenital heart abnormalities may afflict at least 40,000 infants in the United States each year. In the first year of life, roughly 25% of them, or 2.4 (per 1,000 live births), require therapy.
The objective of the report is to present a comprehensive analysis of the market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.
PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.
The report also helps in understanding the global market dynamics, structure by analyzing the market segments and projecting the global market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the global market makes the report investor's guide.
Surgical Glue Market Recent Development
| Date | Company | Development | Impact |
|---|---|---|---|
| 04 August 2025 | Resivant Medical | Resivant Medical secured FDA 510(k) clearance for its CUTIVA Topical Skin Adhesive and CUTIVA PLUS Skin Closure System. | This clearance expands access to sterile 2-octyl cyanoacrylate tissue adhesives featuring self-adhering mesh for enhanced incision closure speed and microbial protection. |
| 15 September 2025 | Medtronic | Medtronic launched its next-generation biodegradable surgical adhesives specifically formulated for high-stress cardiovascular and thoracic procedures. | The initiative expands Medtronic's biosurgery portfolio while offering surgeons a high-tenacity, self-resorbing sealant solution that lowers long-term post-operative complications. |
| 14 October 2025 | Solventum | Solventum introduced its 2487 Hi-Tack Silicone Tape featuring a dual-coated medical adhesive formulation of silicone and acrylate. | The innovation enables medical device manufacturers to integrate gentle, re-positionable, and long-wear skin closure adhesives safe for sensitive and fragile patient skin. |
| 28 April 2026 | Baxter International | Baxter International officially launched a new variant of its Hemopatch Sealing Hemostat featuring room temperature storage capabilities. | Removing strict cold-chain refrigeration requirements improves operating room accessibility and supply chain efficiency for emergency surgical tissue sealing. |
Surgical Glue Market Scope: Inquire before buying
| Surgical Glue Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2034 |
| Historical Data: | 2020 to 2025 | Market Size in 2025: | US $ 8.24 Bn. |
| Forecast Period 2026 to 2034 CAGR: | 9.8% | Market Size in 2034 : | US $ 19.12 Bn. |
| Segments Covered: | by Type | Natural Fibrin Collagen Gelatin Synthetic & Semi-Synthetic Cyanoacrylate Polymeric Hydrogel Urethane-based Adhesive |
|
| by Application | Hospitals Clinics Others Ambulatory Surgery Centers (ASCs) Primary Care Providers (PCPs) |
||
Surgical Glue Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, Turkey, Russia and Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina, Columbia and Rest of South America)
Surgical Glue Market, Key Players are
1. CryoLife Inc.
2. B. Barun Melsungen AG
3. Integra LifeSciences Corporation
4. Baxter International Inc.
5. Advanced Medical Solutions Group plc
6. Cardinal Health
7. CR. Brad
8. OptMed, Inc.
9. Johnson & Johnson
10. Medtronic
11. Medline Industries
12. CSL Limited
13. GEM Srl
14. Tissuemed Ltd.
15. Tricol Biomedical, Inc
16. Others
Frequently Asked Questions:
1. What is the forecast period considered for the Surgical Glue market report?
Ans. The forecast period for the global Surgical Glue market is 2026-2034.
2. Which key factors are expected to hinder the growth of the Surgical Glue market?
Ans. Surgical glue has a number of drawbacks that affect its usability and safety, including allergic responses, wound dehiscence, and skin infections are the key factors expected to hinder the market growth during the forecast period.
3. What is the compound annual growth rate (CAGR) of the Surgical Glue market for the next 6 years?
Ans. The global Surgical Glue market is expected to grow at a CAGR of 9.8% during the forecast period (2026-2034).
4. What are the key factors driving the growth of the Surgical Glue market?
Ans. The people in both developing and developed economies are spending a lot of money on healthcare services as their health concerns grow and their disposable income rises is the key factor expected to drive the growth of the market during the forecast period.
5. Which are the worldwide major key players covered in the Surgical Glue market report?
Ans. CryoLife Inc., B. Barun Melsungen AG, Integra LifeSciences Corporation, Baxter International Inc., Advanced Medical Solutions Group plc, Cardinal Health, CR. Brad, OptMed, Inc., Johnson & Johnson, Medtronic, Medline Industries, CSL Limited, GEM Srl, Tissuemed Ltd., Tricol Biomedical, Inc, and Others are the key players covered.